The Norwegian parent vaccine is considered bio-identical to the MeNZB vaccine – to the extent that Norwegian bridging data was used in lieu of phase three trials.
Norwegian manufactured vaccine was also used in the majority of the trials in New Zealand and an unspecified amount was used in the final rollout.
Researcher/Writer Barbara Sumner Burstyn comments New Zealand seems to be in a state of denial at the extent of the fraud surrounding the development and use of the vaccine. "From the highest levels of government to media and the medical profession, we seem to be desperate to believe everything is fine with this vaccine, despite copious evidence to the contrary."
The documentary reveals that New Zealand officials were warned about serious long-term adverse effects following the meningococcal vaccine in 2003. Officials systematically chose to keep quiet about those serious adverse effects.
"There has clearly been a cover-up by Ministry of Health officials and advisors that warrants a formal inquiry," says Ron Law.
Here is a summary of the Norwegian program:
- - -
Controversial Vaccine Exported
(Norwegian original here)
By Connie Barr, Karen Aarre and Kjell Persen
As Norwegian authorities were paying compensation to vaccine victims, the same vaccine was exported to New Zealand and used on small kids. To say it nice, they enlisted hundreds of thousands of small kids into a gigantic experiment, says Jan Helge Solbakk, professor in medical ethics.
1988 started the largest experiment ever conducted on the Norwegian population. 180,000 school teenagers were used as test subjects in the largest Norwegian vaccine trial ever. It lasted from 1988 to 1991.
The Norwegian Institute for Public Health was testing its new vaccine against meningococcus b, a dangerous bacterium that kills 30 people every year in Norway.
The information brochure given to teenagers states: "it is unlikely to expect serious complications", while the information submitted to the Norwegian Parliament states: "serious side effects can not be excluded" during the experiment.
Jan Helge Solbakk, professor of medical ethics, was working on the ethical side of the trial. He claims: "project leaders knew that trial subjects may suffer serious complications during the trial, statistically speaking."
"Trial subjects were not properly informed about the possibility of serious side effects during the trial. We encouraged the project leaders, during an open meeting, to do it in a better way, informative way" says Solbakk to Dokument 2 TV.
512 side effects were reported during the vaccine trial.
14 were considered serious.
5 school kids developed serious neurological diseases.
During the second trial, involving 53,000 kids, 10 serious side effects were reported, while 1 child developed serious neurological disease.
Worried about the side effects
Hans Cato Guldberg, professor of medicine, was a member of a committee that was to evaluate side effects during the experiment. He was worried.